COVID-19 severity in hospitalized adults compared between Delta and pre-Delta periods

This observational analysis used data from the COVID-NET surveillance network across 14 states to compare the severity of COVID-19 disease among hospitalized adults during periods when the SARS-CoV-2 B.1.617.2 (Delta) variant was predominant versus periods before Delta predominance. All patients included were adults hospitalized with laboratory-confirmed COVID-19. The study did not report the specific sample size, the primary outcome measure, or any quantitative results comparing severity between the two time periods.

No safety or tolerability data were reported for this population-level comparison study. The analysis appears to have examined disease severity patterns rather than specific interventions with associated adverse events.

Key limitations include the absence of reported sample size, specific outcome measures, and quantitative results. The observational design cannot establish causality between variant period and disease severity, as other factors may have differed between time periods. The funding sources and potential conflicts of interest were not reported.

For clinical practice, this analysis suggests surveillance data were examined for potential differences in COVID-19 severity between variant periods, but without reported quantitative findings, the clinical relevance remains unclear. Further details would be needed to understand any potential implications for patient management during different variant waves.